These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32988953)

  • 41. Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic.
    Peach E; Rutter M; Lanyon P; Grainge MJ; Hubbard R; Aston J; Bythell M; Stevens S; Pearce F
    Rheumatology (Oxford); 2021 Apr; 60(4):1902-1909. PubMed ID: 33271595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are Rurality, Area Deprivation, Access to Outside Space, and Green Space Associated with Mental Health during the COVID-19 Pandemic? A Cross Sectional Study (CHARIS-E).
    Hubbard G; Daas CD; Johnston M; Murchie P; Thompson CW; Dixon D
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33917067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic?
    Kipps S; Paul A; Vasireddy S
    Clin Rheumatol; 2021 Apr; 40(4):1575-1579. PubMed ID: 33174109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stratification of the risk of developing severe or lethal Covid-19 using a new score from a large Italian population: a population-based cohort study.
    Corrao G; Rea F; Carle F; Scondotto S; Allotta A; Lepore V; D'Ettorre A; Tanzarella C; Vittori P; Abena S; Iommi M; Spazzafumo L; Ercolanoni M; Blaco R; Carbone S; Giordani C; Manfellotto D; Galli M; Mancia G;
    BMJ Open; 2021 Nov; 11(11):e053281. PubMed ID: 34794995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19: protocol for observational studies utilizing near real-time electronic Australian general practice data to promote effective care and best-practice policy-a design thinking approach.
    Georgiou A; Li J; Pearce C; McLeod A; Wabe N; Hardie RA; Franco GS; Imai C; Sezgin G; Thomas J; Dai Z; Sheikh MK; Proposch A; Weeding S; Wickham B; Badrick T; Murgatroyd D
    Health Res Policy Syst; 2021 Sep; 19(1):122. PubMed ID: 34493295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Common protocol for validation of the QCOVID algorithm across the four UK nations.
    Kerr S; Robertson C; Nafilyan V; Lyons RA; Kee F; Cardwell CR; Coupland C; Lyons J; Humberstone B; Hippisley-Cox J; Sheikh A
    BMJ Open; 2022 Jun; 12(6):e050994. PubMed ID: 35701053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities.
    Abdelmagid N; Ahmed SAE; Nurelhuda N; Zainalabdeen I; Ahmed A; Fadlallah MA; Dahab M
    BMC Public Health; 2021 Jun; 21(1):1153. PubMed ID: 34134680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    Zarif A; Joy M; Sherlock J; Sheppard JP; Byford R; Akinyemi O; Bankhead CR; Deeks A; Ferreira F; Jones N; Liyanage H; McGagh D; Nicholson B; Oke J; Okusi C; Tripathy M; Williams J; Hobbs R; de Lusignan S
    J Infect; 2021 Aug; 83(2):228-236. PubMed ID: 34004222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of COVID-19 outcomes among shielded and non-shielded populations.
    Jani BD; Ho FK; Lowe DJ; Traynor JP; MacBride-Stewart SP; Mark PB; Mair FS; Pell JP
    Sci Rep; 2021 Jul; 11(1):15278. PubMed ID: 34315958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of COVID-19 in shielded and nursing care home patients: a cohort study in general practice.
    Wingfield D; Taghavi Azar Sharabiani M; Majeed A; Molokhia M
    BJGP Open; 2021; 5(6):. PubMed ID: 34446435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National Health Service interventions in England to improve care to Armed Forces veterans.
    Bacon A; Martin E; Swarbrick R; Treadgold A
    BMJ Mil Health; 2022 Feb; 168(1):95-98. PubMed ID: 33741717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of linked patient data to assess the effect of Long-COVID on system-wide healthcare utilisation.
    Murch BJ; Hollier SE; Kenward C; Wood RM
    Health Inf Manag; 2023 Sep; 52(3):167-175. PubMed ID: 35615791
    [No Abstract]   [Full Text] [Related]  

  • 53. The U.S. Needs a National Human Health Observing System.
    Sandifer PA; Singer BH; Colwell RR
    Front Public Health; 2021; 9():705597. PubMed ID: 34552907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the usefulness of Automated Check-in Data Collection in general practice (AC DC Study): a multicentre, cross-sectional study in England.
    Lawton S; Mallen C; Muller S; Wathall S; Helliwell T
    BMJ Open; 2023 Jan; 13(1):e062389. PubMed ID: 36604124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demographic and socioeconomic patterns in healthcare-seeking behaviour for respiratory symptoms in England: a comparison with non-respiratory symptoms and between three healthcare services.
    Morrison KE; Colón-González FJ; Morbey RA; Hunter PR; Rutter J; Stuttard G; de Lusignan S; Yeates A; Pebody R; Smith G; Elliot AJ; Lake IR
    BMJ Open; 2020 Nov; 10(11):e038356. PubMed ID: 33158821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Unsupervised Cluster Analysis of Post-COVID-19 Mental Health Outcomes and Associated Comorbidities.
    Brown KA; Sarkar IN; Crowley KM; Aluthge DP; Chen ES
    AMIA Annu Symp Proc; 2022; 2022():289-298. PubMed ID: 37128434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19.
    Zheng QN; Xu MY; Zheng YL; Wang XY; Zhao H
    Disaster Med Public Health Prep; 2020 Oct; 14(5):652-657. PubMed ID: 32576328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility study of geospatial mapping of chronic disease risk to inform public health commissioning.
    Noble D; Smith D; Mathur R; Robson J; Greenhalgh T
    BMJ Open; 2012; 2(1):e000711. PubMed ID: 22337817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.
    Price E; MacPhie E; Kay L; Lanyon P; Griffiths B; Holroyd C; Abhishek A; Youngstein T; Bailey K; Clinch J; Shaikh M; Rivett A
    Clin Med (Lond); 2020 May; 20(3):256-261. PubMed ID: 32371418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An exploration of factors characterising unusual spatial clusters of COVID-19 cases in the East Midlands region, UK: A geospatial analysis of ambulance 999 data.
    Moore HE; Hill B; Siriwardena N; Law G; Thomas C; Gussy M; Spaight R; Tanser F
    Landsc Urban Plan; 2022 Mar; 219():104299. PubMed ID: 34744229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.